| Record Information |
| Version |
3.5 |
| Creation Date |
2005-11-16 08:48:42 -0700 |
| Update Date |
2013-02-08 17:09:46 -0700 |
| HMDB ID |
HMDB01035 |
| Secondary Accession Numbers |
None |
| Metabolite Identification |
| Common Name |
Angiotensin II |
| Description |
Angiotensin II is a hormone that may act on the central nervous system to regulate renal sympathetic nerve activity, renal function, and, therefore, blood pressure. Angiotensin II is produced locally within the kidney and mediates tissue injury through a series of nonhemodynamic effects. angiotensin II is not only involved in the regulation of blood pressure, water and sodium homeostasis, and control of other neurohumoral systems, but also leads to excessive production of reactive oxygen species and to hypertrophy, proliferation, migration, and apoptosis of vascular cells. Angiotensin II is one of the main factors involved in hypertension-induced tissue damage. This peptide regulates the inflammatory process. Angiotensin II activates circulating cells, and participates in their adhesion to the activated endothelium and subsequent transmigration through the synthesis of adhesion molecules, chemokines and cytokines. Among the intracellular signals involved in angiotensin II-induced inflammation, the production of reactive oxygen species and the activation of nuclear factor-kappaB are the best known. Classical, well-defined actions of Angiotensin II in the brain include the regulation of hormone formation and release, the control of the central and peripheral sympathoadrenal systems, and the regulation of water and sodium intake. As a consequence of changes in the hormone, sympathetic and electrolyte systems, feedback mechanisms in turn modulate the activity of the brain Angiotensin II systems. There are two Angiotensin II systems in the brain. The discovery of brain Angiotensin II receptors located in neurons inside the blood brain barrier confirmed the existence of an endogenous brain Angiotensin II system, responding to Angiotensin II generated in and/or transported into the brain. In addition, Angiotensin II receptors in circumventricular organs and in cerebrovascular endothelial cells respond to circulating Angiotensin II of peripheral origin. Thus, the brain responds to both circulating and tissue Angiotensin II, and the two systems are integrated. (PMID: 17147923 , 16672146 , 16601568 , 16481883 , 16075377 ). |
| Structure |
Download:
MOL |
SDF |
SMILES |
InChI
Display:
2D Structure |
3D Structure
|
| Synonyms |
- 1-8-Angiotensin I
- 1-L-Aspasaginyl-5-L-valyl angiotensin octapeptide
- Ang II
- Angiotensin 2
- Angiotensin II (human)
- Angiotensin II (mouse)
- Angiotonin
- Asp-arg-val-TYR-ile-his-pro-phe
- Human angiotensin II
- Hypertensin
- Ile(5)-angiotensin II
|
| Chemical Formula |
C50H71N13O12 |
| Average Molecular Weight |
1046.1786 |
| Monoisotopic Molecular Weight |
1045.534514801 |
| IUPAC Name |
(3S)-3-amino-3-{[(1S)-1-{[(1S)-1-{[(1S)-1-{[(1S,2S)-1-{[(2S)-1-[(2S)-2-{[(1S)-1-carboxy-2-phenylethyl]carbamoyl}pyrrolidin-1-yl]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]carbamoyl}-2-methylbutyl]carbamoyl}-2-(4-hydroxyphenyl)ethyl]carbamoyl}-2-methylpropyl]carbamoyl}-4-[(diaminomethylidene)amino]butyl]carbamoyl}propanoic acid |
| Traditional IUPAC Name |
(3S)-3-amino-3-{[(1S)-1-{[(1S)-1-{[(1S)-1-{[(1S,2S)-1-{[(2S)-1-[(2S)-2-{[(1S)-1-carboxy-2-phenylethyl]carbamoyl}pyrrolidin-1-yl]-3-(3H-imidazol-4-yl)-1-oxopropan-2-yl]carbamoyl}-2-methylbutyl]carbamoyl}-2-(4-hydroxyphenyl)ethyl]carbamoyl}-2-methylpropyl]c |
| CAS Registry Number |
11128-99-7 |
| SMILES |
CC[C@H](C)[C@H](NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@@H](NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](N)CC(O)=O)C(C)C)C(=O)N[C@@H](CC1=CN=CN1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O |
| InChI Identifier |
InChI=1S/C50H71N13O12/c1-5-28(4)41(47(72)59-36(23-31-25-54-26-56-31)48(73)63-20-10-14-38(63)45(70)60-37(49(74)75)22-29-11-7-6-8-12-29)62-44(69)35(21-30-15-17-32(64)18-16-30)58-46(71)40(27(2)3)61-43(68)34(13-9-19-55-50(52)53)57-42(67)33(51)24-39(65)66/h6-8,11-12,15-18,25-28,33-38,40-41,64H,5,9-10,13-14,19-24,51H2,1-4H3,(H,54,56)(H,57,67)(H,58,71)(H,59,72)(H,60,70)(H,61,68)(H,62,69)(H,65,66)(H,74,75)(H4,52,53,55)/t28-,33-,34-,35-,36-,37-,38-,40-,41-/m0/s1 |
| InChI Key |
CZGUSIXMZVURDU-JZXHSEFVSA-N |
| Chemical Taxonomy |
| Kingdom |
Organic Compounds |
| Super Class |
Amino Acids, Peptides, and Analogues |
| Class |
Peptides |
| Sub Class |
N/A |
| Other Descriptors |
- Angiotensin [KO:K09821](KEGG)
- Aromatic Heteropolycyclic Compounds
- amino acid zwitterion(ChEBI)
|
| Substituents |
- 1,3 Aminoalcohol
- Alpha Amino Acid Or Derivative
- Aminoimidazole
- Amphetamine Or Derivative
- Carboxamide Group
- Carboxylic Acid
- Dicarboxylic Acid Derivative
- Guanidine
- Imidazole
- Imidazolyl Carboxylic Acid Derivative
- N Acyl Alpha Amino Acid
- N Substituted Alpha Amino Acid
- Phenol
- Phenol Derivative
- Polyamine
- Primary Aliphatic Amine (Alkylamine)
- Pyrrolidine
- Secondary Carboxylic Acid Amide
- Tertiary Carboxylic Acid Amide
|
| Direct Parent |
Peptides |
| Ontology |
| Status |
Detected and Quantified |
| Origin |
|
| Biofunction |
Not Available |
| Application |
Not Available |
| Cellular locations |
Not Available |
| Physical Properties |
| State |
Solid |
| Experimental Properties |
| Property |
Value |
Reference |
| Melting Point |
Not Available |
Not Available |
| Boiling Point |
Not Available |
Not Available |
| Water Solubility |
Not Available |
Not Available |
| LogP |
Not Available |
Not Available |
|
| Predicted Properties |
|
| Spectra |
|
Not Available
|
| Biological Properties |
| Cellular Locations |
Not Available
|
| Biofluid Locations |
- Blood
- Cerebrospinal Fluid (CSF)
- Urine
|
| Tissue Location |
Not Available
|
| Pathways |
Not Available
|
| Normal Concentrations |
|
| Blood |
Expected and not Quantified |
|
Not Applicable |
Not Available |
Not Available |
Normal |
Inferred from detection in urine
|
| Cerebrospinal Fluid (CSF) |
Detected and Quantified |
|
6.418e-06 +/- 2.535e-06 uM |
Not Specified |
Not Specified |
Normal |
Not Available |
| Cerebrospinal Fluid (CSF) |
Detected and Quantified |
|
6.418e-06 +/- 2.535e-06 uM |
Adult (>18 years old) |
Female |
normal |
Not Available |
| Urine |
Detected and Quantified |
|
0.0000012 +/- 0.0000002 umol/mmol creatinine |
Adult (>18 years old) |
Both |
Normal |
Not Available |
|
| Abnormal Concentrations |
|
| Blood |
Detected and Quantified |
|
0.0000574 +/- 0.0000030 uM |
Adult (>18 years old) |
Both |
Hypertension |
Not Available |
| Cerebrospinal Fluid (CSF) |
Detected and Quantified |
|
1.922e-06 +/- 1.741e-06 uM |
Adult (>18 years old) |
Not Specified |
neuromyelitis optica spectrum disorders with anti-Anti-aquaporin-4(AQP4) antibody |
Not Available |
| Cerebrospinal Fluid (CSF) |
Detected and Quantified |
|
3.625e-06 +/- 1.473e-06 uM |
Adult (>18 years old) |
Not Specified |
multiple sclerosis |
Not Available |
| Cerebrospinal Fluid (CSF) |
Detected and Quantified |
|
4.907e-06 +/- 2.171e-06 uM |
Adult (>18 years old) |
Not Specified |
inflammatory neuropathies |
Not Available |
| Cerebrospinal Fluid (CSF) |
Detected and Quantified |
|
1.922e-06 +/- 1.741e-06 uM |
Adult (>18 years old) |
Female |
Neuromyelitis optica |
Not Available |
| Cerebrospinal Fluid (CSF) |
Detected and Quantified |
|
5.174e-06 +/- 2.238e-06 uM |
Adult (>18 years old) |
Both |
Other neurological diseases |
Not Available |
| Cerebrospinal Fluid (CSF) |
Detected and Quantified |
|
3.0000e-06 +/- 1.597e-06 uM |
Adult (>18 years old) |
Both |
multiple sclerosis |
Not Available |
|
| Associated Disorders and Diseases |
| Disease References |
| Hypertension |
- Sim MK, Qui XS: Angiotensins in plasma of hypertensive rats and human. Regul Pept. 2003 Mar 28;111(1-3):179-82.
Pubmed: 12609766
|
|
| Associated OMIM IDs |
|
| External Links |
| DrugBank ID |
Not Available |
| Phenol Explorer Compound ID |
Not Available |
| Phenol Explorer Metabolite ID |
Not Available |
| FoodDB ID |
FDB022383 |
| KNApSAcK ID |
Not Available |
| Chemspider ID |
150504  |
| KEGG Compound ID |
C02135  |
| BioCyc ID |
Not Available |
| BiGG ID |
Not Available |
| Wikipedia Link |
Angiotensin II  |
| NuGOwiki Link |
HMDB01035  |
| Metagene Link |
HMDB01035  |
| METLIN ID |
Not Available |
| PubChem Compound |
172198  |
| PDB ID |
Not Available |
| ChEBI ID |
2719  |
| References |
| Synthesis Reference |
Not Available |
| Material Safety Data Sheet (MSDS) |
Not Available
|
| General References |
Not Available |
| Enzymes |
|
|
|
|
| Name: |
Angiotensin-converting enzyme
|
| Reactions: |
- Release of a C-terminal dipeptide, oligopeptide!Xaa-Yaa, when Xaa is not Pro, and Yaa is neither Asp nor Glu. Thus, conversion of angiotensin I to angiotensin II, with increase in vasoconstrictor activity, but no action on angiotensin II COFACTOR Zinc [CPD:C00038] INHIBITOR (S)-N-[3-(3,4-Methylenedioxyphenyl)-2-(mercaptomethyl)-1-oxoprolyl]g lycine [CPD:C01313]
- (S)-N-[3-(3,4-Methylenedioxyphenyl)-2-(mercaptomethyl)-1-oxoprolyl]- (S)-alanine [CPD:C01314]
- (S)-N-[3-(3,4-Methylenedioxyphenyl)-2-(acetylthio)methyl-1-oxoprolyl ]glycine benzyl ester [CPD:C01315]
- (S)-N-[3-(3,4-Methylenedioxyphenyl)-2-(acetylthio)methyl-1-oxoprolyl ]-(S)-alanine benzyl ester [CPD:C01316]
|
| Gene Name: |
ACE |
| Uniprot ID: |
P12821  |
| Protein Sequence: |
FASTA |
| Gene Sequence: |
FASTA |
|
|
|
|
|
|
|
|
|
|
|
|
|